company background image
1SKF401E logo

Zentiva BSSE:1SKF401E Stock Report

Last Price

€31.00

Market Cap

€50.2m

7D

0%

1Y

3.3%

Updated

22 Dec, 2024

Data

Company Financials

1SKF401E Stock Overview

Develops, manufactures, and sells generic medicinal products, primarily used in primary care sector in Slovak, Czech Republic, and internationally. More details

1SKF401E fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends3/6

My Notes

Capture your thoughts, links and company narrative

Zentiva, a.s. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Zentiva
Historical stock prices
Current Share Price€31.00
52 Week High€32.20
52 Week Low€30.00
Beta0
1 Month Change-3.73%
3 Month Change-0.64%
1 Year Change3.33%
3 Year Change1.97%
5 Year Change-79.33%
Change since IPO-96.90%

Recent News & Updates

Recent updates

Shareholder Returns

1SKF401ESK PharmaceuticalsSK Market
7D0%-7.3%-0.1%
1Y3.3%-3.3%1.4%

Return vs Industry: 1SKF401E exceeded the SK Pharmaceuticals industry which returned -3.3% over the past year.

Return vs Market: 1SKF401E exceeded the SK Market which returned 1.4% over the past year.

Price Volatility

Is 1SKF401E's price volatile compared to industry and market?
1SKF401E volatility
1SKF401E Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement5.4%
Market Average Movement4.5%
10% most volatile stocks in SK Market9.7%
10% least volatile stocks in SK Market2.4%

Stable Share Price: 1SKF401E's share price has been volatile over the past 3 months compared to the SK market.

Volatility Over Time: Insufficient data to determine 1SKF401E's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
1992n/an/awww.zentiva.sk

Zentiva, a.s. develops, manufactures, and sells generic medicinal products, primarily used in primary care sector in Slovak, Czech Republic, and internationally. The company offers prescription medicines. It also engages in the production and wholesaling of pharmaceuticals and chemical products.

Zentiva, a.s. Fundamentals Summary

How do Zentiva's earnings and revenue compare to its market cap?
1SKF401E fundamental statistics
Market cap€50.23m
Earnings (TTM)€2.29m
Revenue (TTM)€36.17m

0.0x

P/E Ratio

0.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1SKF401E income statement (TTM)
Revenue€36.17m
Cost of Revenue€13.50m
Gross Profit€22.67m
Other Expenses€20.38m
Earnings€2.29m

Last Reported Earnings

Dec 31, 2018

Next Earnings Date

n/a

Earnings per share (EPS)0
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0.0%

How did 1SKF401E perform over the long term?

See historical performance and comparison

Dividends

155.5%

Current Dividend Yield

n/a

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 06:59
End of Day Share Price 2024/12/11 00:00
Earnings2018/12/31
Annual Earnings2018/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Zentiva, a.s. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution